1 | Medicina | 1.03% | |
2 | Study | 0.95% | |
3 | New | 0.86% | |
4 | Cancer | 0.81% | |
5 | Health | 0.56% | |
6 | Risk | 0.55% | |
7 | May | 0.51% | |
8 | COVID-19 | 0.43% | |
9 | Disease | 0.4% | |
10 | Covid | 0.4% | |
11 | Case | 0.39% | |
12 | Report | 0.37% | |
13 | Patients | 0.36% | |
14 | Hospital | 0.36% | |
15 | HIV | 0.34% | |
16 | Treatment | 0.32% | |
17 | COVID | 0.32% | |
18 | Salud | 0.29% | |
19 | Therapy | 0.27% | |
20 | According | 0.26% | |
21 | Brain | 0.26% | |
22 | Heart | 0.24% | |
23 | Blood | 0.23% | |
24 | Linked | 0.21% | |
25 | Dementia | 0.21% | |
26 | Research | 0.2% | |
27 | Cell | 0.19% | |
28 | Trump | 0.19% | |
29 | Alzheimer’s | 0.19% | |
30 | Could | 0.19% | |
31 | CDC | 0.19% | |
32 | Bienestar | 0.18% | |
33 | UK | 0.18% | |
34 | ASCO | 0.17% | |
35 | Found | 0.17% | |
36 | Doctor | 0.17% | |
37 | AI | 0.17% | |
38 | Covid-19 | 0.17% | |
39 | Be | 0.15% | |
40 | U.S. | 0.15% | |
41 | Diabetes | 0.15% | |
42 | RSV | 0.15% | |
43 | RFK | 0.14% | |
44 | Breast | 0.14% | |
45 | San | 0.14% | |
46 | Sleep | 0.14% | |
47 | Vaccine | 0.14% | |
48 | Clinical | 0.14% | |
49 | Chronic | 0.13% | |
50 | Food | 0.13% | |
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
geneonline.com
2025-06-02 05:06:49
Combination Therapy Superior in Managing Ocular Inflammation During Uveitis
HCPLive
2025-06-02 00:04:53
MS Therapy Cladribine Remains Effective in Patients With Suboptimal Response to Prior Injectable DMT
NeurologyLive
2025-06-02 00:02:33
Dual-target CAR T-cell therapy slows growth of aggressive brain cancer
FirstWord Pharma
2025-06-02 00:00:29
Dual-target CAR T cell therapy slows growth of aggressive brain cancer
Medical Xpress
2025-06-01 21:00:01
Grandfather Diagnosed With Stage Four Lung Cancer Becomes Free of Disease After Immunotherapy
Good News Network
2025-06-01 20:12:29
Gut Bacteria Linked to Cancer Therapy Effectiveness and Immune Cell Interaction
geneonline.com
2025-06-01 09:02:20
From Resistance to Response: The Microbiome’s Role in Optimizing Cancer Therapy
Pharmacy Times
2025-06-01 07:58:55
ASCO: Pre-surgical combination therapy boosts survival in patients with rare thyroid cancer
FirstWord Pharma
2025-06-01 05:26:12
Gene Therapy, ASOs, and Beyond: What’s Coming for Huntington’s Disease
NeurologyLive
2025-06-01 02:02:21
Molecular Assay Identifies Patients With Early NSCLC Likely to Benefit From Adjuvant Chemotherapy
The ASCO Post
2025-06-01 00:00:04
New immunotherapy drug doubles remission time for head and neck cancer patients
Deccan Herald
2025-05-31 19:19:54
Immunotherapy drug 'first breakthrough in 20 years' for head and neck cancer treatment
lbc.co.uk
2025-05-31 09:13:39
Immunotherapy drug helps patients go cancer-free for twice as long, trial shows
Perspective Media
2025-05-31 08:05:07